logo

For the Inventor, By the Inventor

Tel Aviv, Israel

Doron Shabat

USPTO Granted Patents = 13 


Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 72(Granted Patents)


Company Filing History:

goldMedal13 out of 812 
 
Tel Aviv University
 patents
silverMedal1 out of 1 
 
Nemis Technologies Ag
 patent
where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 11931429 - Chemiluminescent probes for diagnostics and in vivo imaging (2024-03-19),
2. 11649475 - Dioxetane compounds and their use for the detection of microorganisms (2023-05-16),
3. 11241507 - Near-infrared chemiluminescent probes for in-vivo imaging (2022-02-08),
4. 11179482 - Chemiluminescent probes for diagnostics and in vivo imaging (2021-11-23),
5. 10660974 - Chemiluminescent probes for diagnostics and in vivo imaging (2020-05-26),
6. 10532113 - Polymeric systems and uses thereof in theranostic applications (2020-01-14),
7. 10420845 - Taggable heteroaromatic drugs and conjugates thereof (2019-09-24),
8. 10071983 - Activatable fluorogenic compounds and uses thereof as near infrared probes (2018-09-11),
9. 9427474 - Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases (2016-08-30),
10. 9341630 - Activatable fluorogenic compounds and uses thereof as near infrared probes (2016-05-17),
11. 9095618 - Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases (2015-08-04),
12. 8658149 - Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases (2014-02-25),
13. 7985573 - Targeted drug-carrying bacteriophages (2011-07-26),

Title: The Innovative Mind of Doron Shabat: A Pioneer in Chemiluminescent Technology

Introduction: Doron Shabat, an esteemed inventor based in Tel Aviv, Israel, has made remarkable contributions to the field of diagnostics and imaging technologies. With a portfolio of 13 patents, Shabat's work showcases his innovative spirit and dedication to advancing scientific knowledge.

Latest Patents: Among his latest inventions, Shabat has developed chemiluminescent probes for diagnostics and in vivo imaging. This invention presents dioxetane-based chemiluminescence probes, specifically fluorophore-tethered dioxetane-based probes and their compositions. These probes hold significant promise for diagnostic applications and improve in vivo imaging techniques. Additionally, he has created dioxetane compounds and their use for detecting microorganisms. This patent focuses on compounds represented by a specific formula, alongside methods for using these dioxetane compounds to identify, quantify, and detect the presence of microorganisms such as bacteria, viruses, and fungi through chemiluminescence.

Career Highlights: Throughout his career, Doron Shabat has collaborated with leading companies in the field, including Ramot at Tel Aviv University Ltd. and Nemis Technologies AG. His work has not only contributed to scientific advancements but has also enhanced the practical applications of diagnostics in medical and research industries.

Collaborations: Shabat has had the privilege of working alongside talented professionals like Ronit Satchi-Fainaro and Ori Green. Their collaborative efforts have resulted in significant strides in the development and application of chemiluminescent technologies.

Conclusion: Doron Shabat's innovative contributions to the fields of diagnostics and in vivo imaging underscore his status as a leading inventor. With a focus on developing advanced chemiluminescent probes and detection methods, his work promises to impact the future of medical diagnostics significantly. His continuing innovations will undoubtedly inspire future advancements in the realm of science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…